Company / Total Debt
Zimmer Biomet Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$6.9B
FY2025
5-year range
$1.0B / $6.9B
FY2021-FY2025
Trend
+29.8%
vs FY2024
Sector context
#16 of 100
Health Care
What the data says
Zimmer Biomet's total debt of $6.9B is higher than 84% of companies in the Health Care sector (FY2025). Total Debt has fluctuated over the past 10 years, ranging from $1.0B in FY2021 to $10.7B in FY2016.
Based on SEC 10-K filings.
$6.9B in FY2025 with a 5-year CAGR of -1.9%. Top quartile in the Health Care sector.
Increased from $4.9B to $6.9B over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +10.4%
- 5-Year CAGR
- -1.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 100This company $6.9B Sector average $4.6B
▼
+52.3% above sector average
Key checks
Key Insights
- 5-year CAGR of -1.9%, indicating a declining trend.
- In FY2025, total debt increased 29.8% year-over-year.
- Ranks #16 out of 100 companies in the Health Care sector.
- Peak total debt was recorded in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.9B | +29.8% |
| FY2024 | $5.3B | +9.7% |
| FY2023 | $4.9B | -5.5% |
| FY2022 | $5.2B | +415.2% |
| FY2021 | $1.0B | -86.9% |
| FY2020 | $7.6B | +13.5% |
| FY2019 | $6.7B | -20.1% |
| FY2018 | $8.4B | -5.6% |
| FY2017 | $8.9B | -16.4% |
| FY2016 | $10.7B | -7.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026